Potential role of anti-interleukin-17 in COVID-19 treatment.

Ayhan, Erhan; Öztürk, Murat; An, Isa; Abdelmaksoud, Ayman; Araç, Esref

Ayhan, Erhan; Öztürk, Murat; An, Isa; Abdelmaksoud, Ayman; Araç, Esref.

Ayhan E; Department of Dermatology, University of Health Sciences Gazi Yasargil Trainning and Research Hospital, Diyarbakir, Turkey.
Öztürk M; Department of Dermatology, Van Trainning and Research Hospital, Van, Turkey.
An I; Department of Dermatology, Sanliurfa Trainning and Research Hospital, Sanliurfa, Turkey.
Abdelmaksoud A; Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
Araç E; Department of Internal Medicine, University of Health Sciences Gazi Yasargil Trainning and Research Hospital, Diyarbakir, Turkey.

Dermatol Ther ; 33(4): e13715, 2020 Jul.

Article in English | MEDLINE | ID: covidwho-787704

Subject(s)

Coronavirus Infections/drug therapy; Interleukin-17/antagonists & inhibitors; Pneumonia, Viral/drug therapy; Animals; Betacoronavirus; COVID-19; Humans; Pandemics; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Interleukin-17 Limits: Animals / Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.13715

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google